Eisai Looks To Multi-Cancer Drug To Reset Global Sales
This article was originally published in PharmAsia News
Executive Summary
Eisai plans to regain its footage in the global drug market by pushing in Europe and the U.S. for approval of a drug aimed at several types of cancer.